Why light-sensing cells may cause retinal pigment layer loss

Identifying the cause for photoreceptor-mediated retinal-pigmented epithelium atrophy

NIH-funded research Univ of Massachusetts Med Sch Worcester · NIH-11082987

This work looks at how the eye's light-sensing cells (photoreceptors) could stress and damage the retinal pigment layer in people with age-related macular degeneration.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniv of Massachusetts Med Sch Worcester NIH-funded
Lab location1 site (Worcester, United States)
Project IDNIH-11082987 on NIH RePORTER

What this research studies

This project focuses on geographic atrophy, a form of age-related macular degeneration where retinal pigment epithelium (RPE) cells are lost and vision declines. Researchers compare photoreceptor metabolism in AMD patients and non-diseased tissue and use experimental models to trace how photoreceptor nutrient use might stress RPE cells. They link patterns of deposits and clinical observations to cellular changes that could explain why RPE patches die. The goal is to identify biological steps that lead to RPE atrophy so future treatments can target those mechanisms.

Who could benefit from this research

Good fit: People with age-related macular degeneration, especially those with early RPE thinning or signs of geographic atrophy, would be most relevant to this work.

Not a fit: People whose vision loss comes from unrelated conditions (for example glaucoma or diabetic retinopathy) are unlikely to get direct benefit from these findings.

Why it matters

Potential benefit: If successful, this work could point to new ways to prevent RPE cell loss and slow or stop geographic atrophy in AMD patients.

How similar studies have performed: Prior research has suggested photoreceptor metabolism links to RPE damage, but translating those findings into treatments is still new and unproven.

Where this research is happening

Worcester, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Bourneville Disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.